Drugs iconDrugsAug 27, 2026

Thyroid Tablets Recalled Nationwide Due To Potential Over-Potency Risk

27, 2026 — More than 3,600 bottles of a common thyroid medication are being recalled nationwide because lab testing showed the pills could be too strong. Vitruvias Therapeutics, based in Auburn, Alabama, initiated the voluntary...

Thyroid Tablets Recalled Nationwide Due To Potential Over-Potency Risk

Share this story

Send the public story page.

Useful takeaways from this story.

27, 2026 — More than 3,600 bottles of a common thyroid medication are being recalled nationwide because lab testing showed the pills could be too strong.

Vitruvias Therapeutics, based in Auburn, Alabama, initiated the voluntary...

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

27, 2026 — More than 3,600 bottles of a common thyroid medication are being recalled nationwide because lab testing showed the pills could be too strong. Vitruvias Therapeutics, based in Auburn, Alabama, initiated the voluntary...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app